Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;99:1347-1354
Published online before print November 2, 2006, doi: 10.1161/01.RES.0000251744.06138.50
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
99/12/1347    most recent
01.RES.0000251744.06138.50v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shaw, J.
Right arrow Articles by Kirshenbaum, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shaw, J.
Right arrow Articles by Kirshenbaum, L. A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Related Collections
Right arrow Apoptosis
Right arrow Cell signalling/signal transduction
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Ischemic biology - basic studies
Right arrow Physiological and pathological control of gene expression
(Circulation Research. 2006;99:1347.)
© 2006 American Heart Association, Inc.


Molecular Medicine

Transcriptional Silencing of the Death Gene BNIP3 by Cooperative Action of NF-{kappa}B and Histone Deacetylase 1 in Ventricular Myocytes

James Shaw, Tong Zhang, Marek Rzeszutek, Natalia Yurkova, Delphine Baetz, James R. Davie, Lorrie A. Kirshenbaum

From the Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, departments of Physiology (T.Z., M.R., N.Y., D.B.), Pharmacology and Therapeutics (L.A.K., J.S.); Manitoba Cancer Treatment Centre (J.R.D.), Faculty of Medicine University of Manitoba, Winnipeg, Manitoba, Canada.

Correspondence to Dr Lorrie A. Kirshenbaum, Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre Rm. 3016, 351 Taché Avenue, Winnipeg, Manitoba, Canada, R2H 2A6. E-mail Lorrie{at}sbrc.ca

Earlier we identified a survival role for NF-{kappa}B in ventricular myocytes, however, the underlying mechanism was undefined. In this report we provide new mechanistic evidence that the hypoxia-inducible death factor BNIP3 is transcriptionally silenced by NF-{kappa}B through a mechanism that involves the cooperative actions of HDAC1. Activation of the NF-{kappa}B signaling pathway in ventricular myocytes suppressed basal and hypoxia-inducible BNIP3 gene activity. Basal Bnip3 gene expression was increased in cells derived from p65–/– deficient mice. The histone deacetylase (HDAC) inhibitor Trichostatin A (TSA 10 nM) suppressed the inhibitory actions of NF-{kappa}B on Bnip3 gene transcription. Basal and hypoxia- induced Bnip3 transcription was repressed by wild type but not a catalytically inactive mutant of HDAC1. Immunoprecipitation assays verified interaction of HDAC1 with wild type p65 NF-{kappa}B and mutations of p65 defective for transactivation in ventricular myocytes. Deletion analysis revealed canonical NF-{kappa}B elements within the Bnip3 promoter to be important for repression of Bnip3 gene expression by HDAC1. Further, the ability of HDAC1 to repress Bnip3 gene transcription was lost in cells derived from p65–/– deficient mice but was restored by repletion of p65 NF-{kappa}B into p65–/– cells. Mutations of p65 NF-{kappa}B defective for DNA binding but not for transactivation abrogated the inhibitory actions of HDAC1 on the Bnip3 gene transcription. Together, our findings provide new mechanistic insight into the cytoprotective actions conferred by NF-{kappa}B that extend to the active transcriptional repression of the death factor Bnip3 through a mechanism that is mutually dependent on HDAC-1.


Key Words: ventricular myocytes • apoptosis • NF-{kappa}B • cell culture




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
G. W. Dorn II
Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling
Cardiovasc Res, February 15, 2009; 81(3): 465 - 473.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Shaw, N. Yurkova, T. Zhang, H. Gang, F. Aguilar, D. Weidman, C. Scramstad, H. Weisman, and L. A. Kirshenbaum
Antagonism of E2F-1 regulated Bnip3 transcription by NF-{kappa}B is essential for basal cell survival
PNAS, December 30, 2008; 105(52): 20734 - 20739.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. L. Hall
Discovery of an Intricate Balance: Gene Transcription, Cell Cycle, and Apoptosis
Circ. Res., February 29, 2008; 102(4): 395 - 397.
[Full Text] [PDF]


Home page
Circ. Res.Home page
N. Yurkova, J. Shaw, K. Blackie, D. Weidman, R. Jayas, B. Flynn, and L. A. Kirshenbaum
The Cell Cycle Factor E2F-1 Activates Bnip3 and the Intrinsic Death Pathway in Ventricular Myocytes
Circ. Res., February 29, 2008; 102(4): 472 - 479.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-D. Ha, D. Ng, J. Lamothe, M. A. Valvano, J. Han, and S. O. Kim
Mitochondrial Proteins Bnip3 and Bnip3L Are Involved in Anthrax Lethal Toxin-induced Macrophage Cell Death
J. Biol. Chem., September 7, 2007; 282(36): 26275 - 26283.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. C. Mahon, P. Baril, V. Bhakta, C. Chelala, K. Caulee, T. Harada, and N. R. Lemoine
S100A4 Contributes to the Suppression of BNIP3 Expression, Chemoresistance, and Inhibition of Apoptosis in Pancreatic Cancer
Cancer Res., July 15, 2007; 67(14): 6786 - 6795.
[Abstract] [Full Text] [PDF]